Hoya Corp (HOCPY)
111.56
-2.12
(-1.86%)
USD |
OTCM |
Apr 19, 16:11
Hoya Net Income (Quarterly): 264.03M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 264.03M |
September 30, 2023 | 330.30M |
June 30, 2023 | 278.50M |
March 31, 2023 | 320.87M |
December 31, 2022 | 216.61M |
September 30, 2022 | 342.51M |
June 30, 2022 | 373.20M |
March 31, 2022 | 339.33M |
December 31, 2021 | 359.45M |
September 30, 2021 | 390.37M |
June 30, 2021 | 376.93M |
March 31, 2021 | 292.87M |
December 31, 2020 | 351.38M |
September 30, 2020 | 300.08M |
June 30, 2020 | 240.54M |
March 31, 2020 | 183.20M |
December 31, 2019 | 271.69M |
September 30, 2019 | 325.06M |
June 30, 2019 | 273.36M |
March 31, 2019 | 264.28M |
December 31, 2018 | 294.15M |
September 30, 2018 | 281.11M |
June 30, 2018 | 261.36M |
March 31, 2018 | 178.71M |
December 31, 2017 | 246.48M |
Date | Value |
---|---|
September 30, 2017 | 244.91M |
June 30, 2017 | 226.75M |
March 31, 2017 | 166.41M |
December 31, 2016 | 229.59M |
September 30, 2016 | 242.84M |
June 30, 2016 | 165.81M |
March 31, 2016 | 162.59M |
December 31, 2015 | 198.07M |
September 30, 2015 | 221.29M |
June 30, 2015 | 192.44M |
March 31, 2015 | 159.08M |
December 31, 2014 | 252.74M |
September 30, 2014 | 261.21M |
June 30, 2014 | 174.23M |
March 31, 2014 | 123.73M |
December 31, 2013 | 205.44M |
September 30, 2013 | 128.74M |
June 30, 2013 | 124.56M |
March 31, 2013 | 263.28M |
December 31, 2012 | 127.22M |
September 30, 2012 | 184.00M |
June 30, 2012 | 289.62M |
December 31, 2011 | 41.95M |
September 30, 2011 | 185.68M |
June 30, 2011 | 187.72M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
183.20M
Minimum
Mar 2020
390.37M
Maximum
Sep 2021
306.86M
Average
320.87M
Median
Mar 2023
Net Income (Quarterly) Benchmarks
Takeda Pharmaceutical Co Ltd | 716.00M |
Nxera Pharma Co Ltd | -1.409M |
PeptiDream Inc | -3.424M |
Stemcell Holdings Inc | 1.037M |
Healios KK | -11.72M |
Net Income (Quarterly) Related Metrics
Revenue (Quarterly) | 1.359B |
Total Expenses (Quarterly) | 605.80M |
EPS Diluted (Quarterly) | 0.7465 |
Enterprise Value | 36.65B |
Gross Profit Margin (Quarterly) | 87.10% |
Profit Margin (Quarterly) | 19.43% |
Earnings Yield | 3.02% |
Operating Earnings Yield | 7.66% |
Normalized Earnings Yield | 3.150 |